Cambiar Investors LLC Bristol Myers Squibb CO Transaction History

Cambiar Investors LLC

$2.49 Billion
Q2 2024

A detailed history of Cambiar Investors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cambiar Investors LLC holds 785,724 shares of BMY stock, worth $41.8 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

785,724

Previous 768,142 2.29%

Holding current value

$41.8 Million

Previous $41.7 Million 21.67%

% of portfolio

1.31%

Previous 1.57%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $707,675 - $931,670	17,582 Added 2.29%	785,724 $32.6 Million
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $1.86 Million - $2.1 Million	-38,670 Reduced 4.79%	768,142 $41.7 Million
Q4 2023 Jan 25, 2024	BUY	$48.48 - $57.85 $3.31 Million - $3.95 Million	68,299 Added 9.25%	806,812 $41.4 Million
Q3 2023 Oct 30, 2023	BUY	$57.89 - $64.73 $5.75 Million - $6.43 Million	99,262 Added 15.53%	738,513 $42.9 Million
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $40.7 Million - $45.2 Million	639,251 New	639,251 $40.9 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $51 Million - $56.1 Million	-701,850 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $851,805 - $1.02 Million	-13,855 Reduced 1.94%	701,850 $51.3 Million
Q4 2021 Jan 27, 2022	SELL	$53.63 - $62.52 $815,980 - $951,241	-15,215 Reduced 2.08%	715,705 $44.6 Million
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $37,099 - $43,457	-627 Reduced 0.09%	730,920 $43.2 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $3.72 Million - $4.05 Million	60,019 Added 8.94%	731,547 $48.9 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $3.41 Million - $3.84 Million	57,516 Added 9.37%	671,528 $42.4 Million
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $12.3 Million - $13.9 Million	213,177 Added 53.18%	614,012 $38.1 Million
Q3 2020 Oct 21, 2020	BUY	$57.43 - $63.64 $23 Million - $25.5 Million	400,835 New	400,835 $24.2 Million
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $30.9 Million - $34.9 Million	-560,751 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $39,615 - $49,376	784 Added 0.14%	560,751 $31 Million
Q1 2018 Apr 26, 2018	SELL	$59.92 - $68.98 $7.46 Million - $8.59 Million	-124,498 Reduced 18.19%	559,967 $35.4 Million
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $2.96 Million - $3.23 Million	-49,425 Reduced 6.73%	684,465 $41.9 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $40.5 Million - $46.8 Million	733,890	733,890 $46.8 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.

Account

Cambiar Investors LLC Bristol Myers Squibb CO Transaction History